Lansforsakringar Fondforvaltning’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.48M Buy
152,073
+1,515
+1% +$54.6K 0.03% 376
2025
Q1
$4.69M Buy
150,558
+214
+0.1% +$6.66K 0.03% 401
2024
Q4
$3.84M Buy
+150,344
New +$3.84M 0.02% 441